NASDAQ: IMMU       Immunomedics Inc
Last Price Today's Change   Day's Range   Trading Volume
30.27   -1.22 (3.87%)  30.11 - 31.98  1,158,678


Avg Volume (4 weeks):2,892,063
4 Weeks Range:30.11 - 35.47
4 Weeks Price Volatility (%):
52 Weeks Range:8.80 - 35.47
52 Weeks Price Volatility (%):
Average Price Target: 8.00
Price Target Upside/Downside: -22.27


No recent Headlines for this stock.

Business Background

Immunomedics Inc is a clinical-stage biopharmaceutical company, based in the United States. The company develops monoclonal antibody-based products for the targeted treatment of cancer and autoimmune disorders, among others. Its portfolio of products under investigation include antibody-drug conjugates that target the tumor-reducing toxic effects of chemotherapeutic treatments. The company’s pipeline includes products targeting solid tumors and hematologic malignancies, among other diseases in clinical and preclinical development. The company is marketing specific diagnostic imaging agents to detect bone infections in Europe, Canada, and Australia. The company has subsidiaries in the Netherlands and Germany to manage sales and clinical trials in Europe.

  Be the first to like this.

I3 Messenger
Individual or Group chat with anyone on I3investor

3305  2442  329  2879 

Top 10 Active Counters
 CIDM 3.55+2.24 
 VISL 1.026+0.601 
 AAL 14.75+2.90 
 GNUS 8.21+0.28 
 NIO 5.995+0.395 
 XSPA 1.70+0.62 
 UAL 38.215+4.565 
 LK 3.33+0.75 
 DAL 31.54+3.07 
 AVP 5.60-0.05 
Partners & Brokers